All In Biotech

Free tool

FAERS Monitor: Tygacil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021821 or its brand name (Tygacil, Tigecycline). Reports on generic versions are filed under their own applications.

Reports

6,220

Serious

5,767

93% of reports

Hospitalization

2,498

Death reported

1,654

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective763
  • off label use696
  • nausea417
  • vomiting283
  • sepsis270
  • thrombocytopenia261
  • death258
  • septic shock243
  • drug resistance225
  • coagulopathy216
  • diarrhoea213
  • condition aggravated205
  • pathogen resistance203
  • product use in unapproved indication181
  • acute kidney injury179

Reports by year received

View as table
YearReports
200520
200676
2007139
2008152
2009175
2010205
2011183
2012159
2013181
2014136
2015215
2016178
2017305
2018329
2019525
2020445
2021473
2022402
2023505
2024598
2025486
2026333

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,939 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pathogen resistanceSignal20377.067.214,821
coagulopathySignal21644.438.99,008
drug resistanceSignal22529.926.36,203
septic shockSignal24319.016.84,108
sepsisSignal2708.27.31,705
thrombocytopeniaSignal2617.97.01,573
acute kidney injurySignal1794.03.4395
off label useSignal6962.72.5768
product use in unapproved indicationSignal1812.52.1159
condition aggravatedSignal2052.32.0148
vomitingSignal2832.01.8151
drug ineffective7632.01.8380
nausea4171.81.6148
diarrhoea2131.11.03
death2581.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.